Koshinski Asset Management, Inc. Biogen Inc. Transaction History

Koshinski Asset Management, Inc.

$1.13 Billion
Q3 2024

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Jan 24, 2023	SELL	$252.44 - $306.72 $10,602 - $12,882	-42 Reduced 5.48%	724 $0
Q3 2022 Oct 18, 2022	BUY	$194.69 - $268.46 $149,132 - $205,640	766 New	766 $205,000
Q2 2022 Jul 12, 2022	SELL	$187.54 - $223.02 $166,535 - $198,041	-888 Closed	0 $0
Q1 2022 Apr 20, 2022	BUY	$193.77 - $244.14 $2,712 - $3,417	14 Added 1.6%	888 $187 Million
Q4 2021 Jan 14, 2022	SELL	$223.92 - $287.77 $8,956 - $11,510	-40 Reduced 4.38%	874 $210 Million
Q3 2021 Oct 12, 2021	BUY	$282.99 - $369.05 $7,640 - $9,964	27 Added 3.04%	914 $258,000
Q2 2021 Jul 26, 2021	SELL	$259.0 - $414.71 $16,058 - $25,712	-62 Reduced 6.53%	887 $307,000
Q1 2021 May 06, 2021	BUY	$242.95 - $284.63 $4,373 - $5,123	18 Added 1.93%	949 $265,000
Q4 2020 Mar 30, 2021	BUY	$236.26 - $355.63 $18,900 - $28,450	80 Added 9.4%	931 $228,000
Q4 2020 Feb 05, 2021	BUY	$236.26 - $355.63 $201,057 - $302,641	851 New	851 $228,000
Q4 2020 Feb 02, 2021	SELL	$236.26 - $355.63 $264,847 - $398,661	-1,121 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$264.77 - $305.71 $33,890 - $39,130	128 Added 12.89%	1,121 $327,000
Q2 2020 Jul 29, 2020	BUY	$258.66 - $342.55 $517 - $685	2 Added 0.2%	993 $266,000
Q1 2020 Apr 30, 2020	SELL	$268.85 - $341.04 $177,978 - $225,768	-662 Reduced 40.05%	991 $314,000
Q4 2019 Jan 29, 2020	BUY	$220.06 - $304.07 $363,759 - $502,627	1,653 New	1,653 $489,000
Q3 2019 Oct 30, 2019	SELL	$217.44 - $243.88 $229,399 - $257,293	-1,055 Closed	0 $0
Q2 2019 Jul 18, 2019	BUY	$219.29 - $241.72 $231,350 - $255,014	1,055 New	1,055 $247,000
Q4 2018 Feb 08, 2019	SELL	$278.5 - $352.75 $198,849 - $251,863	-714 Closed	0 $0
Q3 2018 Nov 15, 2018	BUY	$293.51 - $383.83 $209,566 - $274,054	714 New	714 $252,000

Others Institutions Holding BIIB

# of Institutions

1,032

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Koshinski Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Koshinski Asset Management, Inc. with notifications on news.

Account